Senior Director of Policy, Research and Analysis (Healthcare)

TL;DR

Senior Director of Policy, Research and Analysis (Healthcare): Leading teams to deliver health policy research and analysis for pharmaceutical and biotech clients with an accent on market access and commercialization. Focus on Inflation Reduction Act (IRA) negotiations, drug pricing reforms, and strategic advisory for high-level stakeholders.

Location: Must be based in the U.S. (Preference for Eastern or Central Standard Time Zone; hybrid options available for those in Washington, DC or Austin, TX)

Salary: $154,000 – $200,000

Company

hirify.global is a specialized commercialization partner providing data-informed advice and vision for leaders in healthcare business and policy.

What you will do

• Lead cross-functional teams to meet client deliverables in policy, research, and analysis.
• Provide subject matter expertise on drug pricing, coverage, reimbursement, and benefit design.
• Lead and advise clients on Inflation Reduction Act (IRA) negotiations and manufacturer engagement.
• Manage primary and secondary market research to address project objectives.
• Build and maintain strong C-suite relationships to generate new business opportunities.
• Mentor and develop junior team members (Managers and Associates).

Requirements

• At least 10 years of experience in a pharmaceutical, biotechnology, or consulting firm.
• Deep familiarity with pricing, policy, and manufacturer engagement under IRA provisions.
• Deep knowledge of the pharmaceutical and healthcare industry.
• Advanced degree (MPH, MS, MBA, PharmD, PhD) in health policy, economics, or a relevant discipline preferred.
• Proven experience in leading and developing professional teams.

Culture & Benefits

• Comprehensive medical, dental, and vision insurance.
• 401(k) retirement savings plan with a company safe harbor match.
• Company-funded Health Reimbursement Account (HRA).
• Paid vacation, sick/safe leave, and 8 paid holidays per year.
• Life and short/long-term disability insurance.